[go: up one dir, main page]

NO20066078L - Metode for fremstilling av Entecavir og nye mellomprodukter derav via karbon-silisium oksidasjon - Google Patents

Metode for fremstilling av Entecavir og nye mellomprodukter derav via karbon-silisium oksidasjon

Info

Publication number
NO20066078L
NO20066078L NO20066078A NO20066078A NO20066078L NO 20066078 L NO20066078 L NO 20066078L NO 20066078 A NO20066078 A NO 20066078A NO 20066078 A NO20066078 A NO 20066078A NO 20066078 L NO20066078 L NO 20066078L
Authority
NO
Norway
Prior art keywords
entecavir
preparation
silicon oxidation
via carbon
new intermediates
Prior art date
Application number
NO20066078A
Other languages
English (en)
Inventor
Emily A Reiff
Purushotham Vemishetti
Yadagiri Pendri
Ambarish K Singh
Maotang X Zhou
Siva J Prasad
Ulhas P Dhokte
Zinhua Qian
Kerry B Hartung
Helen Sailes
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20066078L publication Critical patent/NO20066078L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/16—Preparation of ethers by reaction of esters of mineral or organic acids with hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C07F7/0838—Compounds with one or more Si-O-Si sequences
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Silicon Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

Fremgangsmåter for fremstilling av entecavir og nye mellomprodukter for dette, ved anvendelse av karbon-silisium-oksidasjon.
NO20066078A 2004-06-04 2006-12-29 Metode for fremstilling av Entecavir og nye mellomprodukter derav via karbon-silisium oksidasjon NO20066078L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57689904P 2004-06-04 2004-06-04
US11/143,268 US7511139B2 (en) 2004-06-04 2005-06-02 Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation
PCT/US2005/019633 WO2005118585A1 (en) 2004-06-04 2005-06-03 Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation

Publications (1)

Publication Number Publication Date
NO20066078L true NO20066078L (no) 2007-02-01

Family

ID=35449926

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20066078A NO20066078L (no) 2004-06-04 2006-12-29 Metode for fremstilling av Entecavir og nye mellomprodukter derav via karbon-silisium oksidasjon

Country Status (12)

Country Link
US (3) US7511139B2 (no)
EP (1) EP1751158A4 (no)
JP (1) JP5236288B2 (no)
KR (1) KR20070029737A (no)
AU (1) AU2005251377A1 (no)
BR (1) BRPI0510743A (no)
CA (1) CA2569484A1 (no)
IL (1) IL179753A0 (no)
MX (1) MXPA06014003A (no)
NO (1) NO20066078L (no)
RU (1) RU2384582C2 (no)
WO (1) WO2005118585A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100944063B1 (ko) * 2002-12-11 2010-02-24 브리스톨-마이어스 스큅 컴퍼니 항바이러스제[1ｓ-(1알파,3알파,4베타)]-2-아미노-1,9-디히드로-9-[4-히드록시-3-(히드록시메틸)-2-메틸렌시클로펜틸]-6ｈ-퓨린-6-온의 제조 방법
US20070060599A1 (en) * 2005-09-09 2007-03-15 Dimarco John D Crystalline forms of [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one
CN101210015B (zh) * 2006-12-26 2010-09-22 上海国创医药有限公司 一种乙肝治疗药物恩替卡韦的制备方法
CN101245068A (zh) * 2007-02-14 2008-08-20 浙江医药股份有限公司新昌制药厂 结晶型态的恩替卡韦及其制备方法和其药物组合物及用途
CN101284799B (zh) 2007-03-23 2013-04-03 浙江医药股份有限公司新昌制药厂 咖啡酰奎宁酸含氮衍生物及其制备方法和其药物组合物及用途
CN101397333A (zh) 2007-09-27 2009-04-01 浙江医药股份有限公司新昌制药厂 去羟基万古霉素及其制备方法、和其药物组合物及其用途
KR101150254B1 (ko) 2008-12-26 2012-06-12 한미사이언스 주식회사 신규 중간체 및 이를 활용한 엔테카비르 제조방법
CN101828693B (zh) 2009-03-09 2013-01-02 浙江医药股份有限公司新昌制药厂 制备低粘度高流动性类胡萝卜素油悬浮液的方法及其应用
PH12012500703A1 (en) * 2009-10-12 2015-07-10 Hanmi Science Co Ltd Novel method for preparing entecavir and intermediate used therein
CN101781301B (zh) * 2010-01-15 2013-04-10 复旦大学 一种制备恩替卡韦的方法
US8481728B2 (en) * 2010-02-16 2013-07-09 Scinopharm Taiwan, Ltd. Process for preparing entecavir and its intermediates
CN102417506B (zh) * 2010-09-27 2016-04-06 杭州赛利药物研究所有限公司 一种抗病毒药物恩替卡韦的制备方法
EP2693883B1 (en) 2011-04-07 2018-12-26 Cornell University Silyl monomers capable of multimerizing in an aqueous solution, and methods of using same
EP2694707B1 (en) 2011-04-07 2018-08-15 Cornell University Monomers capable of dimerizing in an aqueous solution, and methods of using same
KR101462850B1 (ko) * 2012-05-31 2014-12-04 일동제약주식회사 고순도 엔테카비르 일수화물의 제조방법
CN104177394B (zh) * 2013-05-23 2017-12-05 浙江星月药物科技股份有限公司 恩替卡韦中间体及其制备方法
CN104177396A (zh) * 2013-05-23 2014-12-03 浙江星月药物科技股份有限公司 恩替卡韦中间体及其制备方法
CN107513065B (zh) * 2017-08-03 2021-06-22 浙江华纳药业有限公司 一种恩替卡韦中间体iv制备方法
CN109232637B (zh) * 2018-10-29 2020-11-24 常州博海威医药科技股份有限公司 一种恩替卡韦中间体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4471130A (en) * 1980-08-06 1984-09-11 The Board Of Trustees Of The Leland Stanford Junior University Method for asymmetric epoxidation
US4594439A (en) * 1980-08-06 1986-06-10 The Board Of Trustees Of The Leland Stanford Jr. University Method for asymmetric epoxidation
US4900847A (en) * 1985-04-04 1990-02-13 Massachusetts Institute Of Technology Catalytic asymmetric epoxidation
US5206244A (en) * 1990-10-18 1993-04-27 E. R. Squibb & Sons, Inc. Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
AU4090697A (en) 1996-09-03 1998-03-26 Bristol-Myers Squibb Company Improved process for preparing the antiviral agent {1s-(1alpha, 3alpha, 4beta)}-2-amino-1,9-dihydro-9-{4-hydroxy-3-(hydroxymethyl)-2 -methylenecyclopentyl}-6h-purin-6-one
ATE312613T1 (de) * 2000-02-29 2005-12-15 Bristol Myers Squibb Co Niedrig dosierte entecavir formulierung und deren verwendung
TWI275392B (en) 2002-04-08 2007-03-11 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
KR100944063B1 (ko) 2002-12-11 2010-02-24 브리스톨-마이어스 스큅 컴퍼니 항바이러스제[1ｓ-(1알파,3알파,4베타)]-2-아미노-1,9-디히드로-9-[4-히드록시-3-(히드록시메틸)-2-메틸렌시클로펜틸]-6ｈ-퓨린-6-온의 제조 방법

Also Published As

Publication number Publication date
US20050272932A1 (en) 2005-12-08
MXPA06014003A (es) 2007-02-08
US7786300B2 (en) 2010-08-31
IL179753A0 (en) 2007-05-15
RU2384582C2 (ru) 2010-03-20
KR20070029737A (ko) 2007-03-14
EP1751158A4 (en) 2009-05-13
JP2008501711A (ja) 2008-01-24
CA2569484A1 (en) 2005-12-15
US7511139B2 (en) 2009-03-31
BRPI0510743A (pt) 2007-11-20
EP1751158A1 (en) 2007-02-14
WO2005118585A1 (en) 2005-12-15
RU2006146967A (ru) 2008-07-20
US20100286089A1 (en) 2010-11-11
US20090143578A1 (en) 2009-06-04
US7968555B2 (en) 2011-06-28
JP5236288B2 (ja) 2013-07-17
AU2005251377A1 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
NO20066078L (no) Metode for fremstilling av Entecavir og nye mellomprodukter derav via karbon-silisium oksidasjon
DK1940789T3 (da) Fremgangsmåder og forbindelser til fremstilling af CC-1065-analoger
WO2005108358A3 (en) Pyrrolidine derivatives useful as bace inhibitors
TW200604184A (en) Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
IL172357A0 (en) Method for the production of substituted 3-aryl-butyl amine compounds
ATE381552T1 (de) Derivate von 1-piperazin- und 1- homopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms
TW200624426A (en) BACE inhibitors
EA201100517A1 (ru) Способ получения дабигатрана и его промежуточные соединения
ATE407122T1 (de) Azadecalinmodulatoren des glucocorticoidrezeptors
NO20071254L (no) Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.
NO20072473L (no) Fremgangsmate for fremstilling av kinolinforbindelser og oppnadde produkter
NO20063196L (no) Nye fusjonerte pyrrolokarbazoler
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
EA200501829A1 (ru) Способ получения непептидных замещённых спиробензоазепиновых производных
ATE495243T1 (de) Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
NO20073276L (no) Metode for fremstilling av aminoetoksybenzylalkoholer
DK2436272T3 (da) Hidtil ukendt fremgangsmåde til fødevareproduktion, der omfatter anvendelse af en asparaginase
DK1838670T3 (da) Fremgangsmåde til fremstilling af carvedilol og dets enantiomere
ATE489368T1 (de) Pyrimidinonverbindungen als calcilytica
TW200420530A (en) Novel method for preparing methyl 2-diphenylmethylsulfinylacetate
ATE380183T1 (de) Verfahren zur herstellung von phenyltetrazolderivaten
DK1692105T3 (da) Fremgangsmåde til fremstilling af (3-oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-derivater
NO20053829D0 (no) Fremgangsmate og intermediater for fremstilling av olanzapin.
ATE399167T1 (de) Verfahren zur halbsynthese von deserpidin
DK1490363T3 (da) Fremgangsmåder til fremstilling af 2-7-chlor-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)1-isoindolinon

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BRISTOL-MYERS SQUIBB HOLDINGS IRELAND, CH

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BRISTOL-MYERS SQUIBB HOLDINGS IRELAND, CH

FC2A Withdrawal, rejection or dismissal of laid open patent application